Parkinson’s disease is associated with disability and death. Globally, the rate of occurrence of Parkinson’s disease is increasing faster compared to any other neurological disorder. Out of various therapeutic options available for patients with Parkinson’s disease, deep brain stimulation is gaining popularity. It targets subthalamic nuclei and the globus pallidus internus. Since its approval by the FDA in 2002, deep brain stimulation has experienced significant technological advancements.
Therefore, knowing such innovations can help significantly improve patient care and outcomes. To learn more about deep brain stimulation, join us for an exclusive session on “ Deep Brain Stimulation in Parkinson's Disease” with the renowned neurosurgeon, Dr. R. Ramnarayan , on 1 st March 2023, 6:00 PM IST onwards. Stay tuned!
